-

New Trace-level Online Silica Analyzer Improves Reliability of Process Water Monitoring

Thermo Scientific Orion 8030cX Silica Analyzer enables real-time monitoring of ultrapure water, steam and water chemistry across demanding environments in the power generation, oil and gas, chemical, pulp and paper, and semiconductors industries

CHELMSFORD, Mass.--(BUSINESS WIRE)--A new trace-level silica analyzer for real-time monitoring of ultrapure water, steam and water chemistry can more accurately protect expensive components, including turbines and heat exchangers. The analyzer ensures sustained, energy efficient operations and maximum uptime across the power generation, oil and gas, chemical, pulp and paper, and semiconductor industries.

The new Thermo Scientific Orion 8030cX Silica Analyzer combines a patented fluid delivery system with optimized reagent chemistry to reliably improve silica detection limits to sub-parts-per-billion levels. It delivers accurate and precise results across a wide analysis range, from 0-5000 µg/L. The analyzer demonstrates a 10% improvement in reagent longevity over its competitors - consuming about 200 µL of reagent per test. It can continuously monitor unattended for up to 100 days while simultaneously reducing chemical waste. The improved reagent chemistry minimizes common interferences from phosphate and can be used without performance degradation for over six months (under intermittent operation).

“Impurities in process water can quickly become disruptive and costly without constant surveillance,” said Denzil Vaughn, vice president and general manager for growth protection and separation at Thermo Fisher Scientific. “The Orion 8030cX Silica Analyzer answers that need with direct, accurate online monitoring of silica in real time to prevent built-up, improve energy efficiency and maximize uptime.”

The Orion 8030cX Silica Analyzer features state-of-the-art automation with advanced intuitive functions such as automated calibration, validation and cleaning, intelligent system diagnostics and alert notifications that reduce manual intervention and maintenance. The IP65-rated rugged analyzer provides superior analytical performance in demanding industrial environments.

For more information about the Thermo Scientific Orion 8030cX Silica Analyzer, please visit www.thermofisher.com/orion8030.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media:
Mauricio Minotta
Director, Public Relations
Thermo Fisher Scientific
+1 760-929-2456
Mauricio.minotta@thermofisher.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media:
Mauricio Minotta
Director, Public Relations
Thermo Fisher Scientific
+1 760-929-2456
Mauricio.minotta@thermofisher.com

More News From Thermo Fisher

Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco. The new center provides pharmaceutical and biotechnology innovators with immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights and the development of life-saving therapies. Accelerating Drug Discovery with Cryo-EM The...

Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar**, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species — including Candida auris, a growing global antimicrobial resistance (AMR) threat1. Invasive fungal infections are an increasing challenge for healthcare systems w...

Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner

WEST HILLS, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType™ Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection. For transplant recipients, finding the right tacrolimus dose as early as possible can be life-changing. If the dose is too low, the body may...
Back to Newsroom